Drug Type Small molecule drug |
Synonyms Aur A Kinase Inhibitor - Eli Lilly and Company, AK 01, AK-01 + [3] |
Target |
Action inhibitors |
Mechanism Aurora A inhibitors(Serine/threonine-protein kinase Aurora-A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC4H11N |
InChIKeyYBRBMKDOPFTVDT-UHFFFAOYSA-N |
CAS Registry75-64-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Erbumine | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Small Cell Lung Cancer | Phase 2 | Canada | 29 May 2017 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | Canada | 29 May 2017 | |
Triple Negative Breast Cancer | Phase 2 | Canada | 29 May 2017 | |
Refractory Neuroblastoma | Phase 1 | United States | 11 Jun 2020 | |
Refractory Neuroblastoma | Phase 1 | Japan | 11 Jun 2020 | |
Refractory Neuroblastoma | Phase 1 | Australia | 11 Jun 2020 | |
Refractory Neuroblastoma | Phase 1 | Belgium | 11 Jun 2020 | |
Refractory Neuroblastoma | Phase 1 | France | 11 Jun 2020 | |
Refractory Neuroblastoma | Phase 1 | Germany | 11 Jun 2020 | |
Refractory Neuroblastoma | Phase 1 | Italy | 11 Jun 2020 |
Phase 1/2 | EGFR-mutated non-small Cell Lung Cancer EGFR Mutation | 30 | canjqkhhzl(ytbpugwmqy) = fohopfgugk vjncdxjrvf (hiuzzmdakp ) View more | Positive | 22 Mar 2024 | ||
Not Applicable | Glioblastoma pAURKA (T288) | phospho-Histone H3 (pHH3) | cleaved caspase 3 (CC3) | - | LY3295668 50 mg/kg PO BID x 4 days | mkiuzvbbfz(wjgvmubnis) = ptpyhofksi hxpoktzpsc (ynduehbobz ) View more | Positive | 12 Nov 2021 | |
Placebo | mkiuzvbbfz(wjgvmubnis) = kocwfuwben hxpoktzpsc (ynduehbobz ) View more | ||||||
Phase 1 | 13 | ymiecnydnk(tqhxcewbch) = kupxcyyigr rovafegajr (mqjijbcpdx ) View more | Positive | 01 Aug 2021 | |||
Phase 1/2 | 13 | (25 mg LY3295668 (Phase 2)) | dxkecaszrm = tnsxbmpnyk ushxmxwkvh (impmorwqvy, cppaefeixk - cfhzwjfiyv) View more | - | 02 Jul 2021 | ||
(50 mg LY3295668 (Phase 1)) | gomvkdlzrp = feraqisaeb alkejczljk (lmdkpvgegs, idwrldjlwf - vhdtkiutpp) View more |